The workshop is targeted at 400 clinicians, clinical virologists and nurses working in the public sector who are currently involved in the treatment of patients with HIV and TB in KwaZulu-Natal, South Africa.
This annual workshop attracts clinicians (nurses and doctors and pharmacists) from the private sector and public sector.
Krisp, the Southern African Treatment and Resistance Network (SATuRN) in partnership with CAPRISA ACC will present a full day programme on HIV & TB Drug Resistance and Clinical Management.
Organising Committee
Dr Henry Sunpath (chairperson) KZN Department of Health and University of KwaZulu-Natal, South Africa
Prof. Raj Gandhi Mass General Hospital (MGH), Harvard Medical School, U.S.A.
Prof. Yunus Moosa University of KwaZulu-Natal, South Africa
Prof. Tulio de Oliveira SATuRN & Nelson R Mandela School of Medicine, UKZN, Durban, South Africa
Speakers
Dr. M. Archary University of KwaZulu-Natal, South Africa
Prof. K. Ard Harvard Medical School, U.S.A.
Prof. Linda G. Bekker University of Cape Town, South Africa
Dr. Francesca Conradie WHRI, South Africa
Prof. Tulio de Oliveira SATuRN & Nelson R Mandela School of Medicine, UKZN, Durban, South Africa
Prof. Raj Gandhi Mass General Hospital (MGH), Harvard Medical School, U.S.A.
Prof. R. Goldstein Harvard Medical School, U.S.A.
Dr. Richard Lessells London School of Hygiene and Tropical Medicine, U.K.
Prof. V.C. Marconi Emory University, U.S.A
Prof. I. Master Department of Health and King George V Hospital, South Africa
Prof. S. Mukerji Harvard Medical School, U.S.A.
Dr. Z. Mthembu DREAMS program and MatCH, South Africa
Prof. R. Murphy University of California Los Angeles, U.S.A.
Dr. Kogie Naidoo CAPRISA, South Africa
Prof. Catherine Orrell University of Cape Town, South Africa
Dr. Nesri Padayatchi CAPRISA, South Africa
Prof. M. Siedner Harvard Medical School, U.S.A.
Prof. Francois Venter WHRI, South Africa
One of the main objectives of Krisp, AWACC SATuRN and CAPRISA is to support the NDoH and build capacity among clinicians to manage patients who still present in advanced HIV and TB clinical disease. In addition, we aim to build capacity as part of the CAPRISA ACC to manage patients who fail virologically and those who may need third line ART.
More information on the joint conference, please visit the website below
News date: 2017-09-06
Links:
KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).
Location: K-RITH Tower Building
Nelson R Mandela School of Medicine, UKZN
719 Umbilo Road, Durban, South Africa.
Director: Prof. Tulio de Oliveira